DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

Biogen Idec (NASDAQ: BIIB)

304.21 11.71 (4.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $304.21 4.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $298.48
Previous Close $292.50
Daily Range $293.61 - $304.43
52-Week Range $265.00 - $480.18
Market Cap $71.5B
P/E Ratio 19.75
Dividend (Yield) $0.00 (0.0%)
Volume 2,267,659
Average Daily Volume 3,431,261
Current FY EPS $15.92




Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary

Will Incoming Competitive Threats Sink Biogen?

Safety issues could blunt this company's competitive edge.

Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target?

Biogen: 'A Nice Little Trade' Or Heading To New Lows?

Jim Cramer -- A Fed Rate Hike Won't Stop Profit Opportunities

Applied Genetic Meets Enrolment Milestone in XLRS Study

3 Stocks Pushing The Health Care Sector Downward

We Believe Healthcare's Next Biotech Buyout Target Is…

Which biotech company will be the next buyout target? To answer this question, we turned to three of our healthcare contributors, and this is what they had to say.

Get Ready For The Second Round Of The Market Downturn

Cramer Remains Cautious on Stocks

Biogen And Gilead Sciences Catch The Eye Of Short Sellers

See More BIIB News...

BIIB's Top Competitors

BIIB $304.21 (4.00%)
Current stock: BIIB
GILD $104.27 (2.74%)
Current stock: GILD
AMGN $152.29 (3.28%)
Current stock: AMGN
$0.00 (0.00%)
Current stock: